Hormone Evaluation in Artificial Reproductive Technology
clinical trial
Press Enter · cited answer in seconds
0 sources
Hormone Evaluation in Artificial Reproductive Technology
Summary
Hormone Evaluation in Artificial Reproductive Technology is a clinical trial[1].
Key Facts
- Hormone Evaluation in Artificial Reproductive Technology is in the country of Poland[2].
- Hormone Evaluation in Artificial Reproductive Technology is in the country of Sweden[3].
- Hormone Evaluation in Artificial Reproductive Technology's instance of is recorded as clinical trial[4].
- Hormone Evaluation in Artificial Reproductive Technology's start time is recorded as +2016-09-01T00:00:00Z[5].
- Hormone Evaluation in Artificial Reproductive Technology's end time is recorded as +2020-06-30T00:00:00Z[6].
- Hormone Evaluation in Artificial Reproductive Technology's sponsor is recorded as Lund University[7].
- Hormone Evaluation in Artificial Reproductive Technology's main subject is recorded as infertility[8].
- Hormone Evaluation in Artificial Reproductive Technology's main subject is recorded as ovarian hyperstimulation syndrome[9].
- Hormone Evaluation in Artificial Reproductive Technology's number of participants is recorded as {'unit': '1', 'amount': '+890'}[10].
- Hormone Evaluation in Artificial Reproductive Technology's title is recorded as Prospective Randomised Clinical Study on Pharmacogenetics of Gonadotropin Receptors in Relation to Pregnancy and Life Birth Rate as Well as Unwanted Side Effects Such as Ovarian Hyper Stimulation Syndrome During Assisted Reproduction.[11].
- Hormone Evaluation in Artificial Reproductive Technology's short name is recorded as HEART[12].
- Hormone Evaluation in Artificial Reproductive Technology's ClinicalTrials.gov ID is recorded as NCT03737253[13].
- Hormone Evaluation in Artificial Reproductive Technology's research intervention is recorded as urofollitropin[14].
- Hormone Evaluation in Artificial Reproductive Technology's research intervention is recorded as menotropin[15].
- Hormone Evaluation in Artificial Reproductive Technology's clinical trial phase is recorded as phase IV clinical trial[16].
- Hormone Evaluation in Artificial Reproductive Technology's research site is recorded as Poznań University of Technology[17].
- Hormone Evaluation in Artificial Reproductive Technology's research subject recruitment status is recorded as recruiting[18].
- Hormone Evaluation in Artificial Reproductive Technology's study type is recorded as interventional study[19].